These findings identify TNIK as a novel modulator of ERK5 signaling through both MEK5-dependent and independent mechanisms, highlighting its potential as a therapeutic target for vascular inflammation and endothelial dysfunction. This evidence concerns the gene MAP2K5 and endothelial dysfunction.